Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. annual/quarterly long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Taysha Gene Therapies Inc. long term debt for the quarter ending December 31, 2025 were 50.1M, a 14.03% increase year-over-year.
- Taysha Gene Therapies Inc. long term debt for 2025 were 50.1M, a 14.03% increase from 2024.
- Taysha Gene Therapies Inc. long term debt for 2024 were 43.9M, a 8.48% increase from 2023.
- Taysha Gene Therapies Inc. long term debt for 2023 were 40.5M, a 6.69% increase from 2022.
- Taysha Gene Therapies Inc. long term debt for 2022 were 38.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Taysha Gene Therapies Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $50 |
| 2024 | $44 |
| 2023 | $41 |
| 2022 | $38 |
| Taysha Gene Therapies Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $50 |
| 2024-12-31 | $44 |
| 2023-12-31 | $41 |
| 2022-12-31 | $38 |
Taysha Gene Therapies Inc. Long Term Debt — FAQ
Taysha Gene Therapies Inc. (TSHA) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TSHA's long term debt history?
The chart and table above show Taysha Gene Therapies Inc.'s long term debt by year and by quarter, including the growth rate.